Cell‐specific overactivation of nuclear erythroid 2 p45‐related factor 2–mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury
Authors:
Open Access
- 26 April 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 22 (8) , 1115-1128
Abstract
Hepatic ischemia/reperfusion injury (IRI) is an unavoidable consequence of liver transplantation that can lead to postoperative hepatic dysfunction. Myeloid cells that include Kupffer cells, monocytes, and neutrophils contribute to the inflammatory response and cellular injury observed during hepatic IRI. We hypothesize that overactivation of the nuclear erythroid 2 p45‐related factor 2 (Nrf2)–antioxidant response element (ARE) pathway in myeloid cells leads to decreased cellular damage after hepatic IRI. We constructed transgenic mice with constitutively active nuclear erythroid 2 p45‐related factor 2 (caNrf2) that over activates the Nrf2‐ARE pathway in myeloid cells (lysozyme M cre recombinase [LysMcre]+/caNrf2+, n = 9), and their littermate controls lacking transgene expression (LysMcre+/caNrf2−, n = 11). The mice underwent either sham or partial hepatic ischemia surgery, with 60 minutes of ischemia followed by 6 hours of reperfusion. After IRI, LysMcre+/caNrf2+ mice demonstrated significantly decreased serum alanine aminotransferase and decreased areas of necrosis. Immunohistochemistry and immunoblot of caspase 3 showed a significantly decreased cleaved to full‐length caspase 3 ratio in LysMcre+/caNrf2+ animals. Lymphocyte antigen 6 complex locus G and CD68 staining demonstrated reduced inflammatory cell infiltration. LysMcre+/caNrf2+ animals also had significantly decreased gene expression of proinflammatory cytokines, including interleukin (IL) 1β, IL6, tumor necrosis factor α, chemokine (C‐C motif) ligand 2, and chemokine (C‐X‐C motif) ligand 10, and significantly decreased levels of 8‐isoprostanes. In our model, Nrf2 overactivation in myeloid cells leads to decreased hepatocellular damage, necrosis, apoptosis, inflammation, and oxidative stress. Pharmacologic targeting of the Nrf2‐ARE pathway in myeloid cells may be a novel strategy to mitigate hepatic IRI. Liver Transplantation 22 1115–1128 2016 AASLDKeywords
Funding Information
- National Institutes of Health Center for Advancing Translational Sciences (UL1TR000427)
- American Society of Transplant Surgeons-Pfizer Mid-Level Faculty Award
- National Institutes of Health (T32 CA090217)
- Swiss National Science Foundation (310030_132884)
This publication has 37 references indexed in Scilit:
- Nrf2 Activation Protects the Liver From Ischemia/Reperfusion Injury in MiceAnnals of Surgery, 2014
- Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosisHepatology, 2013
- KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplantsJournal of Hepatology, 2013
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences, 2008
- Mitochondrial Calcium Uptake Regulates Cold Preservation-Induced Bax Translocation and Early Reperfusion ApoptosisAmerican Journal of Transplantation, 2004
- Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray AnalysisJournal of Biological Chemistry, 2003
- An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophenProceedings of the National Academy of Sciences, 2001
- NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURYTransplantation, 1993
- RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSISTransplantation, 1993
- PRESERVATION AND REPERFUSION INJURIES IN LIVER ALLOGRAFTSTransplantation, 1992